Neovacs Aktie - ALNEV

Professionelle Tools für Privatanleger.

Premium

Current Price

0,0034

Gebot

0,0032

Fragen

0,0034

Volumen

16.436.586

0,0032 Tagesbereich 0,0038

0,0001 52-Wochen-Bereich 3,15

Marktkapitalisierung

1,056k

Handelsende

0,0032

Handelsbeginn

0,0034

Letzte Trade

27219

0.0034

Letzter Handelszeitpunkt

10:44:07

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

14.643.198

Ausgegebene Aktien

310.613

Dividendenrendite

Kurs-Gewinn-Verhältnis

0,00

Gewinn pro Aktie (EPS)

-105,96

Erlöse

513k

Nettogewinn

-32,91M

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.neovacs.com

Hauptsitz

Suresnes, Hauts-de-seine, Fra

Gegründet

Neovacs is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker ALNEV. The last closing price for Neovacs was 0,00 €. Over the last year, Neovacs shares have traded in a share price range of 0,0001 € to 3,15 €.

Neovacs currently has 310.613 shares in issue. The market capitalisation of Neovacs is 993,96 € . Neovacs has a price to earnings ratio (PE ratio) of 0.00.

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS COMMUNIQUE DE PRESSE ·...

NEOVACS :

NEOVACS : COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE L’OUVERTURE D’UNE PROCÉDURE DE REDRESSEMENT...

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Paris et...

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ...

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019 Paris et Boston, le 30 octobre 2019 – 17 : 45 CET - NÉOVACS (Euronext Paris :...

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019 COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE SES...

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.001	41.6666666667	0.0024	0.0042	0.0018	47594504	0.00294252	DE
4	-0.0016	-32	0.005	0.0066	0.0018	20122714	0.00327755	DE
12	-0.0321	-90.4225352113	0.0355	0.062	0.0018	14643198	0.01011297	DE
26	-1.1966	-99.7166666667	1.2	1.4	0.0018	6130871	0.01137534	DE
52	-0.0356	-91.2820512821	0.039	3.15	0.0001	17445628	0.00283698	DE
156	-0.1636	-97.9640718563	0.167	3.2	0.0001	22848681	0.00249114	DE
260	-0.0946	-96.5306122449	0.098	4.399	0.0001	65240293	0.00646026	DE

ALNEV - Frequently Asked Questions (FAQ)

What is the current Neovacs share price?

The current share price of Neovacs is 0,0034 €

How many Neovacs shares are in issue?

Neovacs has 310.613 shares in issue

What is the market cap of Neovacs?

The market capitalisation of Neovacs is EUR 993,96

What is the 1 year trading range for Neovacs share price?

Neovacs has traded in the range of 0,0001 € to 3,15 € during the past year

What is the cash to sales ratio of Neovacs?

The cash to sales ratio of Neovacs is 0,22

What is the reporting currency for Neovacs?

Neovacs reports financial results in EUR

What is the latest annual turnover for Neovacs?

The latest annual turnover of Neovacs is EUR 513k

What is the latest annual profit for Neovacs?

The latest annual profit of Neovacs is EUR -32,91M

What is the registered address of Neovacs?

The registered address for Neovacs is 14, RUE DE LA REPUBLIQUE, SURESNES, HAUTS-DE-SEINE, 92150

What is the Neovacs website address?

The website address for Neovacs is www.neovacs.com

Which industry sector does Neovacs operate in?

Neovacs operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ALALOAcheterLouerFR	0,0006 € (50,00%)	2,19M
ALRPDRapid Nutrition	0,0115 € (27,78%)	31,98M
VACBSPierre & Vacances	0,0555 € (23,33%)	37,9k
ALMEXMexedia SPA	6,00 € (17,65%)	19,19k
ALMKTMauna Kea Technologies SA	0,1422 € (15,61%)	749,98k
ORDDSOrdissimo	0,0028 € (-70,83%)	4,51k
CJDSCrossject	0,0113 € (-28,93%)	1,42M
ALCABCabasse SA	0,13 € (-21,45%)	43,15k
ALCBICrypto Blockchain Industries	1,72 € (-19,25%)	1,03M
ALMDTMedian Technologies	1,278 € (-18,49%)	189,2k
ALRPDRapid Nutrition	0,0115 € (27,78%)	31,98M
BCPBanco Comercial Portugues SA	0,6554 € (-2,47%)	17,61M
ALNEVNeovacs	0,0034 € (6,25%)	15,62M
ALSRSSirius Media	0,0026 € (-7,14%)	13,32M
ALHPIHopium SA	0,0004 € (0,00%)	10,32M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Neovacs (ALNEV)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Neovacs

ALNEV Neueste Nachrichten

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

NEOVACS :

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

ALNEV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Neovacs (ALNEV) Börsenkurse

Neovacs (ALNEV)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Neovacs

ALNEV Neueste Nachrichten

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS

NEOVACS :

NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE

POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSE

MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019

NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019

NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER

ALNEV - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen